HEALTHCARE

Healthcare companies allocate 5.9 to 9.3 percent of revenue to marketing, with 14 percent of spend going to events and conferences and 13 percent to public relations. The channel mix reflects an industry where trust and credibility drive purchasing decisions — but it also reflects a measurement gap. Most healthcare marketing functions cannot connect a conference sponsorship or PR placement to a closed deal, because the attribution infrastructure does not exist.

The challenge is compounded by complexity. Regulatory compliance shapes every message. Buying committees include clinicians, administrators, IT directors, and procurement officers — each with different evaluation criteria and risk tolerances. Sales cycles run 12 to 24 months for enterprise health systems. And the cost of a marketing misstep is not a bad campaign — it is a compliance violation that creates legal exposure.

A fractional CMO for healthcare builds the marketing infrastructure that generates pipeline while maintaining the compliance discipline the industry demands — at $96K to $180K per year versus the $355K to $701K cost of a full-time CMO hire.



Three structural problems in healthcare marketing

1. Compliance is used as an excuse, not managed as a workflow.

Compliance constrains claims, testimonials, and clinical assertions. It does not prevent building attribution, defining an ICP, running targeted demand generation, or measuring pipeline. The companies that treat compliance as a blanket excuse for passive marketing lose market share to competitors who build compliant marketing systems. The fractional CMO builds compliance review into the content workflow as a standard step — not a bottleneck that delays every piece by three weeks.

2. Multi-stakeholder committees require segment-specific content.

A hospital CIO evaluates integration and security. A clinical director evaluates patient outcomes. A CFO evaluates total cost of ownership. Procurement evaluates vendor stability. One message cannot serve all four. Healthcare marketing requires persona-specific content for each stakeholder — each compliant, each addressing different evaluation criteria, each supporting the same deal. Most healthcare companies produce one-size-fits-all materials that resonate with none of these buyers.

3. Long cycles with no attribution create a credibility problem.

At 12 to 24 months from first touch to close, the marketing function must prove that the webinar 14 months ago influenced the deal that closed this quarter. Without multi-touch attribution, marketing cannot demonstrate its contribution. The board sees marketing as a cost centre. Budget is cut. Pipeline shrinks. The company becomes sales-dependent — which creates the concentration risk that erodes valuation at exit.